Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting

American Heart Journal

Volumn 161, Issue 3, 2011, Pages 605-610

  Sarafoff, Nikolaus ^a   Neumann, Lydia ^a   Morath, Tanja ^a   Bernlochner, Isabell ^a   Mehilli, Julinda ^a   Schömig, Albert ^a   Kastrati, Adnan ^a   Sibbing, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; FELODIPINE; LERCANIDIPINE; NIFEDIPINE; NILVADIPINE; NITRENDIPINE;

AGED; ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG POTENTIATION; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PRIORITY JOURNAL; RISK ASSESSMENT; STENT THROMBOSIS; STROKE; THROMBOCYTE AGGREGATION;

AGED; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG SYNERGISM; DRUG-ELUTING STENTS; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TICLOPIDINE;

EID: 79952444959     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.11.010     Document Type: Article

References (40)

1. King S.B. III, Smith S.C. Jr., and Hirshfeld J.W. Jr. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 51 2008 172 209
2. Savi P., Pereillo J.M., and Uzabiaga M.F. Identification and biological activity of the active metabolite of clopidogrel Thromb Haemost 84 2000 891 896
3. Hollopeter G., Jantzen H.M., and Vincent D. Identification of the platelet ADP receptor targeted by antithrombotic drugs Nature 409 2001 202 207 (Pubitemid 32144286)
4. Serebruany V.L., Steinhubl S.R., and Berger P.B. Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2005 246 251 (Pubitemid 40094733)
5. Price M.J., Endemann S., and Gollapudi R.R. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
6. Hochholzer W., Trenk D., and Bestehorn H.P. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750 (Pubitemid 44648629)
7. Gurbel P.A., Bliden K.P., and Guyer K. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 2005 1820 1826 (Pubitemid 41579802)
8. Sibbing D., Braun S., and Morath T. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
9. Sibbing D., Schulz S., and Braun S. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement J Thromb Haemost 8 2010 250 256
10. Sibbing D., Steinhubl S.R., and Schulz S. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window J Am Coll Cardiol 56 2010 317 318
11. Sibbing D., Morath T., and Stegherr J. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel Thromb Haemost 101 2009 714 719
12. O'Donoghue M.L., Braunwald E., and Antman E.M. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet 374 2009 989 997
13. Sibbing D., and Kastrati A. Risk of combining PPIs with thienopyridines: fact or fiction? Lancet 374 2009 952 954
14. Sarafoff N., Sibbing D., and Sonntag U. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors Thromb Haemost 104 2010 626 632
15. Bhatt D.L., Cryer B.L., and Contant C.F. Clopidogrel with or without Omeprazole in Coronary Artery Disease N Engl J Med 363 2010 1909 1917
16. Lau W.C., Waskell L.A., and Watkins P.B. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction Circulation 107 2003 32 37 (Pubitemid 36070929)
17. Geisler T., Zurn C., and Paterok M. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy Eur Heart J 29 2008 1635 1643 (Pubitemid 351957543)
18. Sibbing D., von Beckerath N., and Morath T. Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel Eur Heart J 31 2010 1205 1211
19. Katoh M., Nakajima M., and Shimada N. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions Eur J Clin Pharmacol 55 2000 843 852 (Pubitemid 30201767)
20. Siller-Matula J.M., Lang I., and Christ G. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel J Am Coll Cardiol 52 2008 1557 1563
21. Gremmel T., Steiner S., and Seidinger D. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition Heart 96 2010 186 189
22. Price M.J., Nayak K.R., and Barker C.M. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
23. Schulz S., Sibbing D., and Braun S. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents Am Heart J 160 2010 355 361
24. Sibbing D., Braun S., and Jawansky S. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment Thromb Haemost 99 2008 121 126
25. Toth O., Calatzis A., and Penz S. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood Thromb Haemost 96 2006 781 788 (Pubitemid 44883819)
26. Bonello L., Tantry U.S., and Marcucci R. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
27. Cutlip D.E., Windecker S., and Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
28. The TIMI Study Group Definitions used in TIMI trials www.timi.org November In; 2007
29. Siller-Matula JM, Spiel AO, and Lang IM Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel Am Heart J 157 2009 148 e1 5
30. Gilard M., Arnaud B., and Cornily J.C. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 51 2008 256 260
31. Harmsze A.M., Robijns K., and van Werkum J.W. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response Thromb Haemost 103 2010 920 925
32. Sibbing D., Gebhard D., and Koch W. Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy J Thromb Haemost 8 2010 1685 1693
33. Schomig A., Neumann F.J., and Kastrati A. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
34. Leon M.B., Baim D.S., and Popma J.J. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671 (Pubitemid 28550691)
35. Wiviott S.D., Braunwald E., and McCabe C.H. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
36. Wallentin L., Becker R.C., and Budaj A. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
37. Airoldi F., Colombo A., and Morici N. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754 (Pubitemid 47255992)
38. Schulz S, Schuster T, and Mehilli J Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4 year period Eur Heart J 30 2009 2714 2721
39. Buonamici P., Marcucci R., and Migliorini A. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317 (Pubitemid 46891710)
40. Iakovou I., Schmidt T., and Bonizzoni E. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)